Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

nitric oxide

  • You have accessRestricted Access
    The Other Glucose Transporter, SGLT1 – Also a Potential Trouble Maker in Diabetes?
    Mattias Carlström
    JASN April 2019, 30 (4) 519-521; DOI: https://doi.org/10.1681/ASN.2019020171
    Add to Selected Citations
  • You have accessRestricted Access
    Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities
    Chelsea C. Estrada, Alejandro Maldonado and Sandeep K. Mallipattu
    JASN February 2019, 30 (2) 187-200; DOI: https://doi.org/10.1681/ASN.2018080853
    Add to Selected Citations
  • MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension
    You have accessRestricted Access
    MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension
    Yong Liu, Kristie Usa, Feng Wang, Pengyuan Liu, Aron M. Geurts, Junhui Li, Anna Marie Williams, Kevin R. Regner, Yiwei Kong, Han Liu, Jing Nie and Mingyu Liang
    JASN October 2018, 29 (10) 2518-2528; DOI: https://doi.org/10.1681/ASN.2018020117
    Add to Selected Citations
  • You have accessRestricted Access
    Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia
    Miyuki Yokoro, Yosuke Nakayama, Sho-ichi Yamagishi, Ryotaro Ando, Miki Sugiyama, Sakuya Ito, Junko Yano, Kensei Taguchi, Yusuke Kaida, Daisuke Saigusa, Masumi Kimoto, Takaaki Abe, Seiji Ueda and Kei Fukami
    JASN September 2017, 28 (9) 2670-2680; DOI: https://doi.org/10.1681/ASN.2016111184
    Add to Selected Citations
  • You have accessRestricted Access
    Novel Paradigms of Salt and Hypertension
    Wenguang Feng, Louis J. Dell’Italia and Paul W. Sanders
    JASN May 2017, 28 (5) 1362-1369; DOI: https://doi.org/10.1681/ASN.2016080927
    Add to Selected Citations
  • You have accessRestricted Access
    σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury
    Adam Hosszu, Zsuzsanna Antal, Lilla Lenart, Judit Hodrea, Sandor Koszegi, Dora B. Balogh, Nora F. Banki, Laszlo Wagner, Adam Denes, Peter Hamar, Peter Degrell, Adam Vannay, Attila J. Szabo and Andrea Fekete
    JASN January 2017, 28 (1) 152-165; DOI: https://doi.org/10.1681/ASN.2015070772
    Add to Selected Citations
  • You have accessRestricted Access
    Predicting the Functionality and Form of a Dialysis Fistula
    Karl A. Nath and Zvonimir S. Katusic
    JASN December 2016, 27 (12) 3508-3510; DOI: https://doi.org/10.1681/ASN.2016050569
    Add to Selected Citations
  • You have accessRestricted Access
    Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
    Wim Scheele, Susan Diamond, Jeremy Gale, Valerie Clerin, Nihad Tamimi, Vu Le, Rosalind Walley, Fernando Grover-Páez, Christelle Perros-Huguet, Timothy Rolph and Meguid El Nahas
    JASN November 2016, 27 (11) 3459-3468; DOI: https://doi.org/10.1681/ASN.2015050473
    Add to Selected Citations
  • You have accessRestricted Access
    Mineralocorticoid Receptor Antagonism in AKI: A New Hope?
    Luis A. Juncos and Luis I. Juncos
    JASN February 2016, 27 (2) 335-337; DOI: https://doi.org/10.1681/ASN.2015080866
    Add to Selected Citations
  • You have accessRestricted Access
    Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia
    Jonatan Barrera-Chimal, Sonia Prince, Fouad Fadel, Soumaya El Moghrabi, David G. Warnock, Peter Kolkhof and Frédéric Jaisser
    JASN February 2016, 27 (2) 398-404; DOI: https://doi.org/10.1681/ASN.2014121216
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire